Replies to post #1758 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Today’s 8K filing summarizes the recent awards of options and restricted stock to executive officers:

http://sec.gov/Archives/edgar/data/1235010/000110465911010783/a11-6862_18k.htm

These awards are already in the table in #msg-60304685.

[DewDiligence]

MNTA Insider Shareholdings

[Updated for SEC filings through 3/30/11.]


The table entries below include both ordinary and restricted
shares and both vested and non-vested options.

 
                             Shares    Options 
 Officers 
 *Craig Wheeler (CEO)       548,126    775,000 
 *G Venkataraman (SVP/R&D)  412,498    182,820 
 *John Bishop (SVP/Pharma)   99,642    139,862 
 *Richard Shea (CFO)         91,903    272,378 
 *Bruce Leicher (Gen Cnsl)   91,795    160,228 
 *James Roach (CMO)          70,966    228,428 
  
 Directors 
 John Clarke                 77,123    126,000 
 Bruce Downey                     0     45,000 
 Marsha Fanucci                   0    126,000 
 Peter Hutt                  67,863    131,000 
 Thomas Koestler                  0     30,000 
 *Bennett Shapiro             7,000    134,450 
 *Elizabeth Stoner            5,100     64,200 
 James Sulat                  7,000     53,000 
 ======================== =========  ========= 
 All thirteen insiders    1,479,016  2,468,366

*10b5-1 selling plan in effect.